<A HREF="http://sc.ifeng.com/event.ng/Type=click&FlightID=21821&AdID=21594&TargetID=304&Segments=1,160,262,871&Targets=882,196,304,811&Values=34,46,51,81,100,110,204,228,238,263,305,583&RawValues=&Redirect=http://ad.cn.doubleclick.net/click;h=v2|3AFC|0|0|%2a|w;214677492;0-0;0;36519659;31-1|1;21717145|21735035|1;;%3fhttp://www-900.ibm.com/innovation/cn/healthcare/index.shtml?ca=apch_sp-20090511&me=banner&met=sp&re=ifeng&s_tact=chspb002&cm_mmc=apch_sp-20090511-chspb002-_-b-_-sp-_-ifeng" target="_blank"><IMG SRC="http://img.ifeng.com/tres/recommend/client/ibm2007/090512-ibm_finance-950x90.swf" WIDTH=950 HEIGHT=90 BORDER=0></A>

凤凰财经 > 港股 > 综合损益表 > 常茂生化 (08208.HK)
港股代码：

08208 常茂生物化学工程股份有限公司 - H股

综合损益表
单位: 人民币 (元) 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
营业额  418,426,000.00  397,420,000.00  321,440,000.00  299,006,000.00  200,984,000.00
除税前盈利/(亏损)  49,047,000.00  40,696,000.00  74,345,000.00  80,689,000.00  41,309,000.00
税项  -3,413,000.00  -6,078,000.00  -6,987,000.00  -12,102,000.00  -4,128,000.00
除税后盈利/(亏损)  45,634,000.00  34,618,000.00  67,358,000.00  68,587,000.00  37,181,000.00
少数股东权益  295,000.00  30,000.00  --  --  --
股东应占盈利/(亏损)  45,929,000.00  34,648,000.00  67,358,000.00  68,587,000.00  37,181,000.00
股息   10,256,000.00   --   15,041,000.00   22,562,000.00   15,041,000.00
除税及股息后盈利/(亏损)  35,673,000.00  34,648,000.00  52,317,000.00  46,025,000.00  22,140,000.00
基本  6.70  5.10  9.90  10.00  5.40
摊薄  6.70  5.10  9.90  10.00  --
销售成本  328,423,000.00  319,555,000.00  217,228,000.00  190,350,000.00  138,083,000.00
折旧   22,742,000.00   15,095,000.00   12,436,000.00   9,330,000.00   8,264,000.00
利息费用/融资成本   11,852,000.00   10,946,000.00   5,832,000.00   1,659,000.00   1,073,000.00
毛利/(亏损)  90,003,000.00  77,865,000.00  104,212,000.00  108,656,000.00  62,901,000.00
经营盈利/(亏损)  58,112,000.00  50,384,000.00  79,687,000.00  82,348,000.00  42,382,000.00